Bourgeon Capital Management LLC Invests $2.74 Million in Cencora, Inc. $COR

Bourgeon Capital Management LLC purchased a new stake in shares of Cencora, Inc. (NYSE:COR) during the 4th quarter, HoldingsChannel.com reports. The fund purchased 8,124 shares of the company’s stock, valued at approximately $2,744,000.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. IAG Wealth Partners LLC bought a new position in Cencora during the 3rd quarter worth about $30,000. Cloud Capital Management LLC bought a new stake in shares of Cencora in the 3rd quarter valued at about $31,000. Caitlin John LLC purchased a new stake in shares of Cencora in the 3rd quarter worth approximately $31,000. Westside Investment Management Inc. lifted its position in shares of Cencora by 200.0% in the 3rd quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock worth $33,000 after purchasing an additional 70 shares during the period. Finally, Harbor Investment Advisory LLC bought a new position in shares of Cencora during the fourth quarter valued at approximately $35,000. 97.52% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

COR has been the topic of several research reports. Weiss Ratings raised shares of Cencora from a “hold (c+)” rating to a “buy (b)” rating in a report on Thursday, February 5th. Barclays increased their target price on Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a research report on Friday, February 13th. JPMorgan Chase & Co. lifted their price target on Cencora from $417.00 to $419.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Robert W. Baird set a $415.00 price target on Cencora in a research report on Tuesday, January 13th. Finally, Jefferies Financial Group upgraded Cencora from an “underperform” rating to a “buy” rating in a research note on Thursday, January 22nd. Twelve equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $403.17.

Cencora Price Performance

Shares of NYSE COR opened at $313.88 on Wednesday. Cencora, Inc. has a fifty-two week low of $267.40 and a fifty-two week high of $377.54. The company has a market cap of $61.06 billion, a PE ratio of 37.73, a P/E/G ratio of 1.44 and a beta of 0.68. The company has a debt-to-equity ratio of 3.62, a quick ratio of 0.51 and a current ratio of 0.92. The business has a 50-day simple moving average of $350.42 and a two-hundred day simple moving average of $341.25.

Cencora (NYSE:COR) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.04 by $0.04. The firm had revenue of $85.93 billion for the quarter, compared to the consensus estimate of $86.12 billion. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The company’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.73 earnings per share. As a group, equities analysts expect that Cencora, Inc. will post 15.37 EPS for the current fiscal year.

Cencora Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Shareholders of record on Friday, February 13th were paid a dividend of $0.60 per share. The ex-dividend date was Friday, February 13th. This represents a $2.40 dividend on an annualized basis and a yield of 0.8%. Cencora’s dividend payout ratio is presently 28.85%.

Insider Activity

In other Cencora news, CEO Robert P. Mauch sold 5,096 shares of the firm’s stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $354.73, for a total value of $1,807,704.08. Following the completion of the transaction, the chief executive officer owned 66,726 shares of the company’s stock, valued at approximately $23,669,713.98. This trade represents a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.38% of the company’s stock.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.